Manchester University NHS Foundation Trust (MFT) is working with Manchester Metropolitan University’s (MMU) Diverse Talent Scheme which gives graduates with neurodiverse conditions the opportunity to ...

Patients across GM and the UK, will have greater access to cutting-edge treatments and clinical trials following a government announcement of £100m of private investment to set up local research hubs.

New research from Manchester University NHS Foundation Trust (MFT) and co-funded by the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC), has shown ...

An international team of scientists are to set to use thousands of MRI brain scans from research teams around the world in a bid to study Neurofibromatosis Type 1 (NF1), a lifelong neurological ...

In the largest study of its kind globally, UK clinicians and researchers at Royal Manchester Children’s Hospital (RMCH) part of Manchester University NHS Foundation Trust (MFT), and Great Ormond ...

Professor Emma Crosbie, Cancer Prevention and Early Detection Co-Theme Lead at the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) and Honorary ...

Deputy Director NIHR Manchester Clinical Research Facility at Wythenshawe Hospital Dr Alexander Horsley is a leading expert in cystic fibrosis and Deputy Director of ...

Suzanne is a Consultant Paediatrician and researcher at Royal Manchester Children's Hospital with a special interest in epilepsy.

North Manchester General Hospital is now part of the wider family of MFT hospitals creating a Single Hospital Service for Manchester. Manchester Royal Infirmary is a large teaching hospital and ...

Our patients are regularly the first-in-the-world to have the opportunity to trial new treatments, and even more are first in the UK. Research and innovation are key to achieving our vision to be ...

New research from MFT has shown at a DNA-based test is accurate for diagnosing fungal pneumonia caused by Pneumocystis jirovecii in people with weakened immune systems.